Print Page  |  Close Window

VYGR

Voyager Therapeutics Inc
Common Stock

$11.05

-0.75
6.36%
Data as of: 11/14/18  11:05 a.m. ET

Corporate Profile

Voyager Therapeutics is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system.

Our management team has deep expertise and a track record of building exceptional life science companies.

Learn More